Effectiveness of Telehealth Program in Patients With Type 2 Diabetes
NCT ID: NCT05202470
Last Updated: 2023-06-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2022-01-06
2023-05-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Education and Tele-Follow-Up Program on Diabetes Self-Management and Blood Glucose Regulation
NCT06963073
The Effect of Web-Based Education in Patients With Type 2 Diabetes
NCT04626531
The Effect of Education Given to Type 2 Diabetics on Diabetes Self-management, Health Fatalism and Metabolic Parameters
NCT06769477
The Effect of Theory-Based Education on Patient Empowerment and Self-Efficacy in Patients With Type 2 Diabetes
NCT05904847
The Effect of Mobile Application Supported Diabetes Education On Type 2 Diabetes Self-Management And Blood Sugar Level
NCT05228561
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Telehealth Education (TE)
After the first meeting, diabetes education videos prepared in two parts a week will be sent to the mobile phones of the individuals. The video submission will be completed in a total of four weeks.
TE
After the first meeting, diabetes education videos prepared in two parts a week will be sent to the mobile phones of the individuals. The video submission will be completed in a total of four weeks.
Conventional Education (CE)
Paper-based education forms will be given to the patients in the first group. Face-to-face conventional diabetes education will be carried out.
CE
After the first meeting, diabetes education videos prepared in two parts a week will be sent to the mobile phones of the individuals. The video submission will be completed in a total of four weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TE
After the first meeting, diabetes education videos prepared in two parts a week will be sent to the mobile phones of the individuals. The video submission will be completed in a total of four weeks.
CE
After the first meeting, diabetes education videos prepared in two parts a week will be sent to the mobile phones of the individuals. The video submission will be completed in a total of four weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Those between the ages of 18-65,
* Receiving oral antidiabetic and/or insulin therapy,
* Having a mobile phone capable of receiving and playing video messages,
* Does not have hearing, speech and psychiatric problems that prevent communication,
Exclusion Criteria
* Patients who have hearing, speech and psychiatric problems that prevent communication
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Muğla Sıtkı Koçman University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fatih Ozden
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Serap Tuna, PhD
Role: STUDY_CHAIR
Muğla Sıtkı Koçman University
Emine Neşe Yeniçeri, MD
Role: PRINCIPAL_INVESTIGATOR
Muğla Sıtkı Koçman University
Cem Şahin, MD
Role: PRINCIPAL_INVESTIGATOR
Muğla Sıtkı Koçman University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Muğla Training and Research Hospital
Muğla, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Mugla Sıtkı Kocman
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.